257 results on '"Ringel, Yehuda"'
Search Results
2. Mesenteric panniculitis is associated with cardiovascular risk-factors: A case-control study
3. Endoscopic findings and esophageal cancer incidence among Fanconi Anemia patients participating in an endoscopic surveillance program
4. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities
5. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders
6. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
7. Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects
8. Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
9. Probiotics in functional bowel disorders
10. Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagus.
11. Upadacitinib for Acute Severe Ulcerative Colitis.
12. 14 PAIN-REDUCTION EFFECT OF A RATIONALLY-DESIGNED LIVE BACTERIAL CONSORTIUM FOR TREATMENT OF IBS BASED ON MICROBIOME FUNCTIONAL GENOMICS ANALYSIS
13. Tu1704 A 1470 NM DIODE LASER DEVICE FOR TREATMENT OF FECAL INCONTINENCE: RESULTS OF A PRECLINICAL STUDY IN A PORCINE MODEL
14. Burden of Gastrointestinal Disease in the United States: 2012 Update
15. Alterations in the Intestinal Microbiota and Functional Bowel Symptoms
16. Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome
17. Randomized, Controlled Trial Shows Biofeedback to be Superior to Alternative Treatments for Patients with Pelvic Floor Dyssynergia-Type Constipation
18. Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study
19. Treatment of functional diarrhea
20. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity
21. Regional Brain Activation in Response to Rectal Distension in Patients with Irritable Bowel Syndrome and the Effect of a History of Abuse
22. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
23. Biofeedback treatment of fecal incontinence: A critical review
24. Prebiotics and the Health Benefits of Fiber: Current Regulatory Status, Future Research, and Goals1,2
25. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
26. Dietary prebiotics: current status and new definition
27. The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans
28. The Burden of Gastrointestinal and Liver Diseases, 2006
29. Digestive and liver diseases statistics, 2004
30. Functional Chest Pain of Presumed Esophageal Origin
31. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
32. Fluctuations of Lipid and Lipoprotein Levels in Hyperlipidemic Postmenopausal Women Receiving Hormone Replacement Therapy
33. One-Week Triple Therapy With Omeprazole, Clarithromycin, and Nitroimidazole for Helicobacter pylori Infection in Children and Adolescents
34. The effects of phospholipid molecular species on cholesterol crystallization in model biles: the influence of phospholipid head groups
35. Flexible sigmoidoscopy: The patients' perception
36. Metformin Enhances Clearance of Chylomicrons and Chylomicron Remnants in Nondiabetic Mildly Overweight Glucose-Intolerant Subjects
37. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.
38. Psychosocial Aspects of Crohn's Disease
39. 397 MICROBIOME GENOMICS REVEALS NOVEL BACTERIAL STRAINS ASSOCIATED WITH IRRITABLE BOWEL SYNDROME SYMPTOMS AND DISEASE SEVERITY.
40. Tu1774 – Microbiome Functionalgenomics Reveals Novel Bacterial Strains for Reduction of Inflammation in Crohn's Disease
41. Mo1715 – The Israeli Multi Center “Swallow and Forget” Study: Prepless X-Ray Imaging Capsule with Enhanced Algorithms Shows Substantial Improvement in Polyp Detection
42. Randomized Clinical Trial: Lactobacillus Acidophilus NCFM Affects Colonic Mucosal Opioid Receptors Expression in Human Patients with Functional Abdominal Pain
43. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
44. Microbiome-Based Diagnostics: Ready for Applications in Laboratory Medicine?
45. Alterations in Composition and Diversity of the Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
46. Wireless pH-Motility Capsule for Colonic Transit: Prospective Comparison with Radiopaque Markers in Chronic Constipation
47. Luminal and Mucosal-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
48. Tu1108 - Practice Differences in the Diagnosis and Management of Adult and Pediatric Eosinophilic Esophagitis
49. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
50. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.